The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care
Autor Ibis Sanchez Serranoen Limba Engleză Paperback – 4 iun 2019
This book is useful to researchers, advanced students, regulators, and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.
- Explores the current state-of-the-art in the pharmaceutical industry and the global healthcare sector
- Includes insights from world-leading figures in the pharmaceutical industry, healthcare sector, federal funding agencies, regulatory bodies, investment sector, entrepreneurship, intellectual property law, philanthropic organizations, and advocacy groups
- Develops in-depth, original concepts, which have important implications in the understanding of, and search for, potential solutions to the world´s health care crisis
Preț: 469.06 lei
Preț vechi: 588.45 lei
-20% Nou
Puncte Express: 704
Preț estimativ în valută:
89.81€ • 93.52$ • 74.51£
89.81€ • 93.52$ • 74.51£
Carte tipărită la comandă
Livrare economică 07-21 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128142936
ISBN-10: 0128142936
Pagini: 174
Dimensiuni: 152 x 229 x 12 mm
Greutate: 0.27 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128142936
Pagini: 174
Dimensiuni: 152 x 229 x 12 mm
Greutate: 0.27 kg
Editura: ELSEVIER SCIENCE
Public țintă
Researchers, advanced students and management in the pharmaceutical industry and disease foundations. Healthcare professionals, FDA staff, business graduates, anyone interested in medical technology development, and scientific innovation.,Cuprins
Part I1. Introduction: the remarkable success story of the development of bortezomib2. Lessons from the development of bortezomib: the Core Model
Part II3. The “Core: when innovation meets leadership 4. “The Bridge: collaboration is the best catalyst to success5. “The Periphery: the efficient use of underused societal resources
Part III6. Biopharmaceutical intellectual property, financial interests, and the Core Model7. Global health care crisis, the pharmaceutical industry, and the Core Model8. The Core Model, innovation, economic growth, development, and policy-making
Part IV9. Conclusion: the Core Model: a novel economic theory10. Epilogue: the Core Model and other industries
Part II3. The “Core: when innovation meets leadership 4. “The Bridge: collaboration is the best catalyst to success5. “The Periphery: the efficient use of underused societal resources
Part III6. Biopharmaceutical intellectual property, financial interests, and the Core Model7. Global health care crisis, the pharmaceutical industry, and the Core Model8. The Core Model, innovation, economic growth, development, and policy-making
Part IV9. Conclusion: the Core Model: a novel economic theory10. Epilogue: the Core Model and other industries